Captrust Financial Advisors Denali Therapeutics Inc. Transaction History
Captrust Financial Advisors
- $34.2 Billion
- Q4 2024
Shares
3 transactions
Others Institutions Holding DNLI
# of Institutions
240Shares Held
111MCall Options Held
80KPut Options Held
36.8K-
Black Rock Inc. New York, NY13.2MShares$175 Million0.01% of portfolio
-
Baillie Gifford & CO12.3MShares$163 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$160 Million0.0% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.48MShares$72.7 Million0.02% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U05.36MShares$71.1 Million0.55% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $1.78B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...